While revenue for the full year rose by 3% y-o-y to $16.6 million, the company posted a loss before tax of $37.4 million due mainly to higher other losses and fees, especially finance costs which rose by 377% y-o-y to $11.6 million.
The Singapore Institute of Advanced Medicine Holdings (SAM) has reported a loss after tax and total comprehensive loss for the year of $37.4 million for the FY2024 ended June 30, more than twice its losses of $18.1 million in year before.
SAM’s 2HFY2024 loss also deepened by 75% y-o-y to $16.2 million from $9.3 million in the 2HFY2023.
